Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials
Andrea Casadei Gardini,1* Marco Puzzoni,2* Francesco Montagnani,3* Giorgia Marisi,4* Emiliano Tamburini,5 Alessandro Cucchetti,6,7 Leonardo Solaini,6,7 Francesco Giuseppe Foschi,8 Fabio Conti,8 Giorgio Ercolani,6,7 Stefano Cascinu,1 Mario Scartozzi21Division of Medical Oncology, Department of Medica...
Main Authors: | Casadei Gardini A, Puzzoni M, Montagnani F, Marisi G, Tamburini E, Cucchetti A, Solaini L, Foschi FG, Conti F, Ercolani G, Cascinu S, Scartozzi M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/profile-of-lenvatinib-in-the-treatment-of-hepatocellular-carcinoma-des-peer-reviewed-article-OTT |
Similar Items
-
Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment
by: Nanna Bæk Møller, et al.
Published: (2019-09-01) -
Brivanib治疗肝癌的临床研究进展
by: QI Xingshun
Published: (2014-04-01) -
THE SIDE EFFECTS OF SORAFENIB, SUNITINIB, AND TEMSIROLIMUS AND THEIR THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
by: N. Bhojani, et al.
Published: (2014-08-01) -
THE SIDE EFFECTS OF SORAFENIB, SUNITINIB, AND TEMSIROLIMUS AND THEIR THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
by: N. Bhojani, et al.
Published: (2014-08-01) -
Molecular pharmacokinetic determinants of anticancer kinase inhibitors in humans
by: Julie Scholler, et al.
Published: (2011-06-01)